Ixaka
Catherine Girault is a seasoned Quality Assurance professional with extensive experience in the pharmaceutical and biotechnology sectors. At Rexgenero France, Catherine has served as a Quality Assurance Coordinator since 2017, overseeing QA activities, managing processes, and ensuring continuous improvement of the Quality System. Prior to this role, Catherine worked as a QA CMO specialist at EFFIK and LFB, focusing on quality management for marketed and investigational products, regulatory compliance, and quality event management. Additional experience includes quality assurance roles at L'Oréal, Guerbet, and Ferring Pharmaceuticals, where skills in SOP management, documentation review, and support for regulatory inspections were honed. Catherine holds a Master's degree in Industrial Biology Process Engineering from Ionis-STM and a Master's degree in Cellular and Molecular Biology from Pierre and Marie Curie University.
This person is not in any offices
Ixaka
1 followers
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.